Concepedia

Author

Theresa Westphal

Paracelsus Medical University

Also Known As

T Westphal, T. Westphal, Theresa Westphal

19

Publications

424

Citations

10

H-Index

11

Concepts

All Affiliations

Paracelsus Medical UniversityInnsbruck Medical UniversityUniversity of CologneUniversität InnsbruckUniversity Hospital Cologne
TW

About

Theresa Westphal is an author at Paracelsus Medical University specializing in medicine, vaccine development, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

39

2

Immunology

1

1

12

3

Pharmacology

1

1

27

4

Drug Development

1

1

27

5

Drug Discovery

1

1

27

Theresa Westphal

×

8

Publications

359

Citations

8

H-Index

YearCitations

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer

Florian Huemer, Gabriel Rinnerthaler, Theresa Westphal,

Oncotarget

2018

88

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)

Simon Peter Gampenrieder, Andreas Peer, Christian Weismann,

Breast Cancer Research

2019

77

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade

Florian Huemer, David Lang, Theresa Westphal,

Journal of Clinical Medicine

2019

73

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial

Theresa Westphal, Gabriel Rinnerthaler, Simon Peter Gampenrieder,

Cancer Medicine

2018

34

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors

Richard Riedel, Jana Fassunke, Hannah L. Tumbrink,

European Journal of Cancer

2022

27

Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer

Diana Schaufler, David Ast, Hannah L. Tumbrink,

npj Precision Oncology

2021

25

Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations

Matthias Scheffler, Alessandra Holzem, Anna Kron,

Lung Cancer

2020

23

LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

Sjoukje F. Oosting, Astrid A.M. van der Veldt, Corine H. GeurtsvanKessel,

Annals of Oncology

2021

12

Page 1